AXGN

#4287
Axogen, Inc. - Common Stock
0.3 9 USD
-99.02%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
0.39
0.39
년간 변동
0.39
45.75
일일 변동
-99.02%
월간 변동
-99.07%
6달 변화
-98.64%
년간 변동율
-97.84%
이전 종가
40.4 2
Open
0.3 9
저가
0.3 9
High
0.3 9
양
121
전체 차트 열기 Full chart

Financials

개요 성명 통계 배당금
4분기 연간
  • Market Capitalization 20.99 M
  • Employee 622
  • Founded 2002
  • CEO N/A
  • Website www.axogeninc.com
  • Headquarter Minnesota, United States
  • FIGI BBG000BN46R9
  • Industry 의료 기기
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-96.26
주가매출액비율
6.69

Axogen, Inc. - Common Stock

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use.

뉴스